UHRF1 and cancer: Similarly, advanced drug screening and design (including virtual library and high-throughput screening, bioinformatics, and structure-based tools) are necessary to develop more specific and direct inhibitors of UHRF1 with a broad spectrum of activity against various cancers with minimal off-target effects.